The present disclosure provides materials and methods for the continuous measurement of biomolecules in vivo and in real-time. The present disclosure relates more specifically to using capture agents and detection agents within a microfluidic device to detect and quantify biochemical features of biomarkers, enabling real-time detection and concentration measurements.

Provided herein are methods and systems of molecular profiling of diseases, such as cancer. In some embodiments, the molecular profiling can be used to identify treatments for a disease, such as treatments that were not initially identified as a treatment for the disease or not expected to be a treatment for a particular disease.

A method of automatically distinguishing absorption or non-absorption of whole blood or blood plasma by using a reflective photosensor in an automatic immunoassay device including a round cartridge which may simultaneously perform the centrifugation and automatic analysis of a blood sample and a tip which may be moved up, down, left and right based on the round cartridge, the method includes: installing the reflective photosensor below the round cartridge; mounting the tip above the round cartridge, and continuously measuring blood non-absorption data in a range including a position where the blood is absorbed by using the reflective photosensor, collecting the measured data and storing the collected data while the tip is raised; continuously measuring blood absorption data by using the reflective photosensor while the tip is lowered and absorbs the blood present in the range including the position where the blood is absorbed from the round cartridge; and determining whether a type of the blood is whole blood or blood plasma, or whether the whole blood or the blood plasma is not absorbed by comparing the blood non-absorption data with the blood absorption data.

An air sampling system is disclosed. The air sampling system includes: an air inflow channel having an air inlet portion at a top end, the air inflow channel being oriented substantially vertically; a fan configured to cause air in a sampling environment to flow into the air inflow channel via the inlet portion; a cooling unit for cooling air in the air inflow channel, the cooling unit disposed downstream of the inlet portion; a collection chamber for collecting liquid water condensed from air in the air inflow channel, the collection chamber being fluidly connected to the air inflow channel; and a sensing unit for determining a volume of liquid in the collection chamber, wherein the cooling unit is controlled in response to signals generated by the sensing unit.

Superparamagnetic nanoparticle-based analytical method comprising providing a sample having analytes in a sample matrix, providing a point of care chip having analytical regions, each of which is a stationary phase having at least one or more sections, labeling each of the analytes with a superparamagnetic nanoparticle and immobilizing the labeled analytes in the stationary phase, providing an analytical device having a means for exciting the superparamagnetic nanoparticles in vitro and a means for sensing, receiving, and transmitting response of the excited superparamagnetic nanoparticles, placing the chip in the analytical device and exciting the superparamagnetic nanoparticles in vitro, sensing, receiving, and transmitting the response of the superparamagnetic nanoparticles, and analyzing the response and determining characteristic of the analytes, wherein the response of the superparamagnetic nanoparticles comprises harmonics. The present invention also provides the hybrid point of care chip and analyzer to be used in the analytical method.

In a method of detecting a test substance, a test substance is detected using a sample analysis cartridge supplied with a sample. The sample analysis cartridge includes: a passage part having a gas-phase space; and liquid containers communicating with the passage part through openings. The liquid containers include: a first liquid container containing a first liquid containing magnetic particles; and a second liquid container containing a second liquid containing a labeled substance. The magnetic particles are sequentially transported to the liquid containers through the gas-phase space in the passage part. Thus, the magnetic particles carry a complex of the test substance and the labeled substance. The test substance is detected based on the labeled substance in the complex.

Embodiments of the present disclosure provide a target capturing apparatus and a manufacturing method thereof, and a target detecting method. The target capturing apparatus includes a cavity structure, the cavity structure includes: an inlet portion, an outlet portion and a capture region positioned between the inlet portion and the outlet portion, and the capture region includes a capture component, and a combination specifically combined with a to-be-captured target is included in the capture component so as to capture the target in a sample entering the cavity structure.

A system for time-resolved fluoroimmunoassay detection is disclosed. The system comprises a receptacle with a sample volume adapted for receiving a sample therein; a light source adapted to emit pulsed excitation light illumination optics adapted to collect the pulsed excitation light from the light source and to deliver the pulsed excitation light to the sample volume in the receptacle; a detection device adapted for gated detection of fluorescence radiation at least in a detection spectral range; detection optics adapted to collect fluorescence radiation from the receptacle at least in the detection spectral range and deliver the fluorescence radiation to the detection device; and an optical filter device configured for the separation of excitation light and detection light. A method for time-resolved fluoroimmunoassay detection is also provided.

A flexible planar patch suitable for application to a patient's skin is provided. The planar patch comprises a capture layer (100) and a cover layer (200). The capture layer (100) comprises an analyte capture zone (105) and a fastener zone (104). The analyte capture zone (105) consists of a first water permeable material comprising a ligand capable of binding specifically to an analyte. The fastener zone (104) is impermeable to water and/or delimited from said analyte capture zone by a water impermeable barrier zone (108) and comprises an adhesive (133) capable of fastening the capture layer (100) removably to a surface. The cover layer comprises an adhesive (233) capable of fastening the cover layer (200) removably to the capture layer (100). In addition, a kit for assembly of the patch and a diagnostic method using the patch are provided.

A method includes capturing a signal of a detection substrate exposed to a sample containing a target substance; determining that the detection substrate is in a testable state; and generating an assessment of the presence of the target substance in the sample.